IFNA1 and hepatocellular carcinoma: Interferons (IFNs), including type 1 IFNs alpha (IFN-α) and beta (IFN-β), are anticancer agents and IFN-α preparations have been used as adjuvant therapy for patients after hepatic resection of HCC and found to be safe.